MAP3K8 anticorps (AA 368-397) (APC)
Aperçu rapide pour MAP3K8 anticorps (AA 368-397) (APC) (ABIN1911791)
Antigène
Voir toutes MAP3K8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 368-397
-
Specificité
- This COT (MAP3K8/MEKK8) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 368-397 amino acids from the C-terminal region of human COT (MAP3K8/MEKK8).
-
Purification
- Protein G purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Date de péremption
- 6 months
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Autre désignation
- MAP3K8 / TPL2
-
Sujet
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
ID gène
- 1326
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling
Antigène
-